Taken together, our data suggest that both early-stage autophagy inhibitor candidates, SBI and VPS34-IN1, affect the survival of BRAFV600E CNS tumor cells during both short- and long-term in vitro growth analyses, irrespective of their BRAFi sensitivity. Here, PIK3C3 is linked to central nervous system neoplasm.